Bassem Morcos

Medical Director, Clinical Development (neuromuscular Disease) at PepGen

No bio yet

Links

Previous companies

Org chart

No direct reports

Teams

This person is not in any teams

Offices

This person is not in any offices

PepGen

2 followers

Driven by its proprietary Enhanced Delivery Oligonucleotide (EDO) platform, PepGen is creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic diseases, with an initial focus on neuromuscular diseases.

Industries

Biotechnology

Headquarters

Cambridge, United States

Employees

11-50

Links